Haematologica (May 2024)

CD22-targeted glyco-engineered natural killer cells offer a further treatment option for B-cell acute lymphoblastic leukemia

  • Xin Jin,
  • Rui Sun,
  • Zhu Li,
  • Xianwu Wang,
  • Xia Xiong,
  • Wenyi Lu,
  • Hairong Lyu,
  • Xia Xiao,
  • Yunpeng Tian,
  • Hongkai Zhang,
  • Zhihong Fang,
  • Luqiao Wang,
  • Mingfeng Zhao

DOI
https://doi.org/10.3324/haematol.2023.284241
Journal volume & issue
Vol. 999, no. 1

Abstract

Read online

Not available.